A genetically humanized mouse model for hepatitis C virus infection
about
Evidence for novel hepaciviruses in rodentsViral Evasion of Natural Killer Cell ActivationRecent advances in understanding hepatitis CMolecular changes in hepatic metabolism and transport in cirrhosis and their functional importanceEntry inhibitors: New advances in HCV treatmentNatural killer cells in hepatitis C: Current progressAnimal models for the study of HCVHepatitis C virus comes for dinner: How the hepatitis C virus interferes with autophagyGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignNew hepatitis C virus drug discovery strategies and model systemsMurine models of hepatitis C: what can we look forward to?Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseasesNTCP and beyond: opening the door to unveil hepatitis B virus entryMouse models of hepatitis B virus infection comprising host-virus immunologic interactionsT cell responses in hepatitis C virus infection: historical overview and goals for future researchThe hepatitis C virus glycan shield and evasion of the humoral immune responseNeutralizing antibody response to hepatitis C virusMurinization of internalin extends its receptor repertoire, altering Listeria monocytogenes cell tropism and host responsesIn Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus GenotypesMouse Systems to Model Hepatitis C Virus Treatment and Associated ResistanceStructural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization EscapeThe impact of hepatitis C virus entry on viral tropismProteomic approaches to analyzing hepatitis C virus biologyMathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entryHuman monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolateA novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmissionAnalysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolutionRapid generation of a mouse model for Middle East respiratory syndrome.Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain.Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designAdvancement in the development of models for hepatitis C research.Prediction and prevention of the next pandemic zoonosis.Hepatitis C virus induces CD81 and claudin-1 endocytosis.Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgroundsThe missing pieces of the HCV entry puzzle.A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized miceThree-dimensional in vivo imaging of the murine liver: a micro-computed tomography-based anatomical study
P2860
Q21089595-8D9D3DE6-64FC-4933-B341-2C33CF44BC96Q26748421-5262715F-AAC4-444F-B2B8-4A269BD1F3A2Q26766136-7F158D7F-5422-4A41-A008-465B3BC26F8DQ26769609-1D42D8CB-3DC1-41E9-9879-0F71694D87A1Q26770817-9C6061AA-85F2-40B7-AB46-A758366E0108Q26773264-282BA07D-4DF8-42CC-BA59-A6082ED8E6B1Q26797836-2D064A2A-69D7-4014-8E60-688E6ECB1E73Q26801207-35B6D985-283D-4EC4-8E50-44BC7733A3EDQ26801759-1BF20BB7-A906-4F0A-962E-6577048D345BQ26851159-7E6192C5-CB29-453C-B776-BD8954FCBD81Q26991875-4B3871C5-3393-46DC-B8F2-4110A0AEA73CQ26992256-A8CB06D7-F209-4D61-BACB-991EFD1238AFQ26999712-9DED7370-ACC0-475D-9512-DF6EC2CF5A6BQ27002598-217B6870-23B6-493B-A267-46B76F69A2C3Q27003510-21B68DDF-444D-40EC-A633-E20C3810E999Q27023390-6A237A50-F40C-4721-84D9-1548C1AE04DBQ27027484-368FF65B-5B69-4FD0-BC01-0C750AA2A3DCQ27334739-3D0BC1A5-D506-4E26-B22A-7424A55B5DD5Q27468929-F40294A9-BB20-403D-8D5F-08AF78C358F9Q27469038-0DFD0BEF-3D46-4D95-92F4-AD570DC3A262Q27678252-3A3D7D4D-92AE-4CBD-95DB-008DED1F9AF3Q27693297-EA6C4FBD-BC89-4C41-A918-6C77A890B8FDQ28085146-1E73CB62-0B85-4E25-8DC0-7143D9646FE3Q28478310-E7418B94-2294-4F8E-89E4-E4D42AFEE6D2Q28482261-4868B7C3-40A1-42A1-AF52-DDA5DCD87670Q28488372-B6378A20-12D4-4366-84CB-D6302E7D7CBDQ28659586-D0116DEF-E6B5-40F2-A1F7-7BFC899B88AEQ30217177-A8A5A828-F2D7-4832-BFE3-B1E6DFF5E1DCQ30364309-47064125-0C81-43D3-9E19-FDE1C83592F4Q30374314-6BA699D3-9723-48B8-A7EA-A015BD9DFE46Q30418069-FA84E1A1-6AAA-4685-A893-BF99B082FCAEQ30424289-49BF18F3-92E5-4D71-BA81-B22F1377EB82Q30512696-6D9C5BC5-6472-4873-B110-37A5D0BA4276Q30532816-AFF97C4D-9AE8-4340-B7C0-7F005FD5ADD4Q33360674-C4A0F79B-32F2-4667-9C3B-55AAFEE87A12Q33648339-6EE3A5F1-314A-48A2-B240-25DC6DA934E9Q33899640-8A30F5F4-6EFF-4BBF-91A4-9B007971E812Q34047477-C4DF9A47-949F-4019-9EB7-4C2541958DFAQ34124403-D648DD01-B4F0-4A7A-81C3-6CE75580A5D9Q34170590-19D0E03A-701E-436C-AF18-06718F7C00F7
P2860
A genetically humanized mouse model for hepatitis C virus infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A genetically humanized mouse model for hepatitis C virus infection
@ast
A genetically humanized mouse model for hepatitis C virus infection
@en
type
label
A genetically humanized mouse model for hepatitis C virus infection
@ast
A genetically humanized mouse model for hepatitis C virus infection
@en
prefLabel
A genetically humanized mouse model for hepatitis C virus infection
@ast
A genetically humanized mouse model for hepatitis C virus infection
@en
P2093
P2860
P50
P356
P1433
P1476
A genetically humanized mouse model for hepatitis C virus infection
@en
P2093
Alexander Ploss
Charles M Rice
Christopher T Jones
Dennis R Burton
John W Schoggins
Joshua A Horwitz
Justin B Robbins
Mansun Law
P2860
P2888
P304
P356
10.1038/NATURE10168
P407
P577
2011-06-08T00:00:00Z
P5875
P6179
1008801396